NEWSAR
Multi-perspective news intelligence
E

Elahere

Topic Health

Mirvetuximab soravtansine, sold under the brand name Elahere, is a medication used as a treatment for epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. Mirvetuximab soravtansine is a folate receptor alpha directed antibody and microtubule inhibitor conjugate.

Total Coverage:0 articles
Last 7 Days:0
View on Wikipedia →

Coverage Timeline

Related Entities

England
location•1 mentions
Nice
location•1 mentions
NHS England
organization•1 mentions
ovarian cancer
topic•1 mentions
National Institute for Health and Care Excellence
organization•1 mentions
AbbVie
organization•1 mentions
mirvetuximab soravtansine
topic•1 mentions
Ruth Plummer
person•1 mentions